1. Home
  2. PRQR vs FCT Comparison

PRQR vs FCT Comparison

Compare PRQR & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • FCT
  • Stock Information
  • Founded
  • PRQR 2012
  • FCT 2004
  • Country
  • PRQR Netherlands
  • FCT United States
  • Employees
  • PRQR N/A
  • FCT N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • FCT Finance Companies
  • Sector
  • PRQR Health Care
  • FCT Finance
  • Exchange
  • PRQR Nasdaq
  • FCT Nasdaq
  • Market Cap
  • PRQR 309.5M
  • FCT 265.0M
  • IPO Year
  • PRQR 2014
  • FCT N/A
  • Fundamental
  • Price
  • PRQR $1.27
  • FCT $9.91
  • Analyst Decision
  • PRQR Strong Buy
  • FCT
  • Analyst Count
  • PRQR 6
  • FCT 0
  • Target Price
  • PRQR $8.50
  • FCT N/A
  • AVG Volume (30 Days)
  • PRQR 694.9K
  • FCT 106.8K
  • Earning Date
  • PRQR 03-13-2025
  • FCT 01-01-0001
  • Dividend Yield
  • PRQR N/A
  • FCT 11.29%
  • EPS Growth
  • PRQR N/A
  • FCT N/A
  • EPS
  • PRQR N/A
  • FCT N/A
  • Revenue
  • PRQR $20,235,014.00
  • FCT N/A
  • Revenue This Year
  • PRQR $39.44
  • FCT N/A
  • Revenue Next Year
  • PRQR N/A
  • FCT N/A
  • P/E Ratio
  • PRQR N/A
  • FCT N/A
  • Revenue Growth
  • PRQR 196.41
  • FCT N/A
  • 52 Week Low
  • PRQR $1.25
  • FCT $9.45
  • 52 Week High
  • PRQR $4.62
  • FCT $10.42
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 22.66
  • FCT 23.29
  • Support Level
  • PRQR $1.25
  • FCT $10.13
  • Resistance Level
  • PRQR $1.39
  • FCT $10.30
  • Average True Range (ATR)
  • PRQR 0.09
  • FCT 0.08
  • MACD
  • PRQR -0.01
  • FCT -0.02
  • Stochastic Oscillator
  • PRQR 3.92
  • FCT 4.88

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.

Share on Social Networks: